← Latest Filings
F

Flagship Pioneering, LLC

Also a 13F filer: see its fund portfolio and quarterly moves →

Open-market buys
3
$75.0M total
Open-market sells
0
$0 total
Tracking since
Mar 2026
Activity timeline
Open-market buy — $25.0M
Generate Biomedicines, Inc. · Mar 2, 2026
Open-market buy — $25.0M
Generate Biomedicines, Inc. · Mar 2, 2026
Open-market trades from the last two years.

1 more trades. A free account shows you more; Premium shows every one.

Log in
Holdings as last reported
2,235,468 Pre-Funded Warrants to purchase Common Stock in FHTX
Held indirectly (By Flagship Pioneering Fund VII, L.P.) · as of 2026-01-13
1,117,734 Series 1 Warrants to purchase Common Stock in FHTX
Held indirectly (By Flagship Pioneering Fund VII, L.P.) · as of 2026-01-13

1 more holdings. A free account shows you more; Premium shows every one.

Log in
Companies touched
Foghorn Therapeutics Inc.
CIK 0001822462